Analyst Ratings for Prelude Therapeutics (PRLD)
PRLD Rating Summary
PRLD Price Target Summary
- Highest: $5.00 (H.C. Wainwright)
- Lowest: $3.00 (Citizens)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$4.00 (+23.8%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/19/2024 | H.C. Wainwright » Updated 9/23/2025 |
Robert Burns | Upgrade | Buy (Neutral) |
5.00 (N/A) |
2.44 (3.23) |
32.38% | Details |
| 6/20/2024 | Barclays » Updated 10/28/2024 |
Peter Lawson | Downgrade | Underweight (Equalweight) |
1.00 (3.00) |
3.93 (3.23) |
-17.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
